Literature DB >> 11676855

Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.

S Sakajiri1, N Kawamata, M Egashira, K Mori, K Oshimi.   

Abstract

Natural killer (NK) cell neoplasms, which are derived from mature or precursor NK cells, are rare diseases and are observed predominantly in Asian countries. We analyzed the status of the Rb, p53, p15INK4B, p16INK4A and p14ARF genes in these diseases by Southern blot, polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) and western blot analysis. We used 31 NK cell neoplasms, including four cell lines derived from NK cell neoplasms, 3 myeloid / NK cell precursor acute leukemias, 4 blastic NK cell lymphoma / leukemias, 4 aggressive NK cell leukemia / lymphomas, 4 nasal NK cell lymphomas, and 12 chronic NK lymphocytosis. We found gene amplification of the p53 gene in one nasal NK cell lymphoma, and point mutations of the p53 gene in one blastic NK cell lymphoma / leukemia and one chronic NK lymphocytosis. In addition, homozygous deletions of p15, p16 and p14 genes in 5 out of 31 samples were detected; 3 were from nasal NK cell lymphoma and 2 from blastic NK cell lymphoma / leukemia. Also hemizygous deletion of the Rb gene in one blastic NK cell lymphoma was detected. Rb proteins were highly expressed in one cell line as well as two myeloid / NK cell precursor acute leukemias. In other cell lines, complete loss and an aberrant migration pattern of Rb protein expression were observed. Comparative genomic hybridization suggested that the homozygous deletions of the p15, p16 and p14 were subtle chromosomal deletions and could not be identified by standard karyotyping in some cases. Although the number of cases we analyzed was not large, alterations identified in the Rb, p53, p16, p15 and p14 genes are of significance and might be associated with tumorigenesis in NK cell neoplasms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676855      PMCID: PMC5926606          DOI: 10.1111/j.1349-7006.2001.tb01059.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

Review 1.  EBV-NK cells interactions and lymphoproliferative disorders.

Authors:  H Kanegane; A Yachie; T Miyawaki; G Tosato
Journal:  Leuk Lymphoma       Date:  1998-05

Review 2.  Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.

Authors:  H G Drexler; Y Matsuo
Journal:  Leukemia       Date:  2000-05       Impact factor: 11.528

Review 3.  Lymphoproliferative disorders of natural killer cells.

Authors:  K Oshimi
Journal:  Int J Hematol       Date:  1996-06       Impact factor: 2.490

4.  Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.

Authors:  L L Siu; K F Wong; J K Chan; Y L Kwong
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

5.  Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.

Authors:  A K Chiang; A C Chan; G Srivastava; F C Ho
Journal:  Int J Cancer       Date:  1997-11-04       Impact factor: 7.396

6.  Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.

Authors:  L Quintanilla-Martinez; J L Franklin; I Guerrero; L Krenacs; K N Naresh; C Rama-Rao; K Bhatia; M Raffeld; I T Magrath
Journal:  Hum Pathol       Date:  1999-07       Impact factor: 3.466

7.  Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.

Authors:  J A DiGiuseppe; D C Louie; J E Williams; D T Miller; C A Griffin; R B Mann; M J Borowitz
Journal:  Am J Surg Pathol       Date:  1997-10       Impact factor: 6.394

Review 8.  Regulatory networks of the retinoblastoma protein.

Authors:  W H Lee; P L Chen; D J Riley
Journal:  Ann N Y Acad Sci       Date:  1995-03-27       Impact factor: 5.691

9.  Mutations of the p53 gene in adult T-cell leukemia.

Authors:  A Sakashita; T Hattori; C W Miller; H Suzushima; N Asou; K Takatsuki; H P Koeffler
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

Review 10.  The MDM2 gene amplification database.

Authors:  J Momand; D Jung; S Wilczynski; J Niland
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

View more
  10 in total

Review 1.  NK/T Cell Lymphoma: Updates in Therapy.

Authors:  Ritsuro Suzuki
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

Review 2.  Natural killer-cell neoplasms.

Authors:  John P Greer; Claudio A Mosse
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

Review 3.  NK cell lymphoma.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 4.  NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.

Authors:  Ritsuro Suzuki
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

Review 5.  Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.

Authors:  Holbrook Kohrt; Ranjana Advani
Journal:  Leuk Lymphoma       Date:  2009-11

Review 6.  Leukemia and lymphoma of natural killer lineage cells.

Authors:  Kazuo Oshimi
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 7.  Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.

Authors:  Keisei Kawa
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

8.  Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.

Authors:  Kei-ji Sugimoto; Norihiko Kawamata; Sakura Sakajiri; Kazuo Oshimi
Journal:  Jpn J Cancer Res       Date:  2002-11

9.  Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition.

Authors:  Ly Quoc Trung; J Luis Espinoza; Akiyoshi Takami; Shinji Nakao
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

10.  Epstein-Barr virus renders the infected natural killer cell line, NKL resistant to doxorubicin-induced apoptosis.

Authors:  Y Isobe; K Sugimoto; I Matsuura; K Takada; K Oshimi
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.